Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs State Street PDR S&P Retail ETF (XRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs State Street PDR S&P Retail ETF — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.45 (market cap $2.27B), while State Street PDR S&P Retail ETF trades at $83.65 (market cap $389.66M). The key difference: SELLAS Life Sciences Group Inc. Common Stock is far larger — about 5.8× State Street PDR S&P Retail ETF's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, State Street PDR S&P Retail ETF nearer its low. Which is the better fit depends on your goals.
| SLS | XRT | |
|---|---|---|
Market Cap | $2.27B | $389.66M |
Volume | 4,179,659 | 4,275,820 |
Sector | Health | Broad Market / Factor |
52-Week High | $15.46 | $92.35 |
52-Week Low | $1.39 | $77.28 |
Enterprise Value | $2.14B | — |
Typical Hold Time | — | 44 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XRT (SPDR S&P Retail ETF) trades at $83.45, up 0.65% with a bullish technical signal despite bearish moving averages. The ETF faces mixed sentiment as retail sales show volatility, with August's 1.2% rebound contrasting July's 0.6% decline. Key resistance sits at $85, while RSI-6 at 84.45 indicates potential overbought conditions. Recent news highlights holiday sales projections exceeding $1 trillion but concerns over consumer spending shifts toward value-oriented purchases.
Outlook remains cautious amid macroeconomic pressures; higher interest rates and inflation weigh on consumer sentiment, with analysts expecting continued underperformance versus broader markets. The ETF's equal-weight approach provides diversification, but selective consumer spending patterns and oil price volatility pose near-term risks. Investment appeal hinges on holiday season performance and Federal Reserve policy direction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About State Street PDR S&P Retail ETF
XRT is an equal-weighted ETF that tracks the U.S. retail sector. It provides diversified exposure to apparel, automotive, and online retailers, including well-known names like Amazon, Target, and Costco.
Read more on XRT →
